Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Duchenne muscular dystrophy (DMD)
Podcast
A heartwarming review of cardiovascular news, most-loved stories
This week on "The Top Line," we celebrate Valentine's Day with a discussion about heart-related updates and the stories we've loved covering in 2025.
Andrea Park
,
Gabrielle Masson
Feb 14, 2025 9:00am
Sarepta's Elevidys blows sales expectations out of the water
Nov 7, 2024 3:43pm
FDA broadens label for Sarepta's Duchenne gene therapy Elevidys
Jun 21, 2024 7:51am
Italfarmaco wins FDA's blessing for nonsteroidal DMD therapy
Mar 22, 2024 11:05am
PTC, after rejections, will try again with Translarna at the FDA
Mar 19, 2024 10:10am
Elevidys gains steam amid Sarepta's efforts to widen FDA label
Feb 29, 2024 4:11pm
